Victoza release date?

When was Victoza first released (approved/marketed)?

Victoza (liraglutide) was first approved for use in the European Union on 30 January 2009 [1]. It then had a U.S. release (FDA approval) on 25 January 2010 [2].

What do people mean by “release date” for Victoza?

Searches for “release date” usually refer to one of these:
- Regulatory approval date (when the drug is officially approved).
- Time it reached the market (often close to approval, but can vary by country and rollout).

The dates above are the drug’s key regulatory approval milestones in the EU and U.S. [1][2].

How does this relate to patents and exclusivity?

If you’re tracking “release” to estimate when competition might enter (e.g., generics or other GLP-1 products), patent and exclusivity timelines can differ by country and by patent term. DrugPatentWatch.com tracks related patent details and can be a useful place to check [3].

Sources

1. European Medicines Agency (EMA) – Victoza EPAR (authorisation date 30 Jan 2009)
   
2. FDA – Victoza (liraglutide) approval (25 Jan 2010)
   
3. DrugPatentWatch.com – Victoza (liraglutide) patent information